Healy James |
Non-Executive Director |
BioAge Labs, Inc. (BIOA)
|
2024-09-27 |
$18.00 |
0.0% |
666,665
|
$11,999,970 |
Healy James |
Non-Executive Director |
Rapport Therapeutics, Inc. (RAPP)
|
2024-07-01 |
$24.52 |
-13.5% |
44,032
|
$1,079,575 |
Healy James |
Non-Executive Director |
Rapport Therapeutics, Inc. (RAPP)
|
2024-06-10 |
$17.00 |
24.8% |
558,824
|
$9,500,008 |
Healy James |
Non-Executive Director |
ArriVent Biopharma, Inc. (AVBP)
|
2024-01-30 |
$18.00 |
47.8% |
444,444
|
$7,999,992 |
Healy James |
Non-Executive Director |
Karuna Therapeutics, Inc. (KRTX)
|
2022-06-30 |
$122.80 |
168.6% |
120,000
|
$14,736,158 |
Healy James |
Non-Executive Director |
Karuna Therapeutics, Inc. (KRTX)
|
2022-04-01 |
$129.38 |
154.9% |
47
|
$6,081 |
Healy James |
Non-Executive Director |
Natera, Inc. (NTRA)
|
2021-07-22 |
$113.00 |
4.0% |
2,400
|
$271,200 |
Healy James |
Non-Executive Director |
Karuna Therapeutics, Inc. (KRTX)
|
2021-07-02 |
$117.80 |
180.0% |
636
|
$74,923 |
Healy James |
Non-Executive Director |
Bolt Biotherapeutics, Inc. (BOLT)
|
2021-02-09 |
$20.00 |
-96.8% |
450,000
|
$9,000,000 |
Healy James |
Non-Executive Director |
Karuna Therapeutics, Inc. (KRTX)
|
2020-09-09 |
$73.75 |
347.2% |
4,557
|
$336,079 |
Healy James |
Non-Executive Director |
Karuna Therapeutics, Inc. (KRTX)
|
2020-09-08 |
$71.74 |
359.8% |
62,282
|
$4,467,908 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
66.5% |
$39,567,769 |
$59,471,894 |